Subject: Growth Hormone (GH) Therapy*. Effective Date: July 29, 2003. Department(s): Utilization Management. Policy: Treatment with GH (HCPCS J2941) is reimbursable under Plans. administered by QualCare, Inc. for the indications listed below. Objective: To provide proper and consistent reimbursement for and to ensure.
Branch and is intended to preserve the role of CRS as a confidential resource. decision whether and how to place individual CRS products in the public domain. congressional publications, or through their own web sites. CRS for individual congressional clients, should be maintained. interpreted broadly.
It is recommended that the minutes contain a record of what is done and not what is said. If the minutes are to be published, in addition to the information described below, they should contain a list of speakers on each side of the question with an abstract text of each address. Committee reports are printed in full and what action was taken on them. At this meeting it would be wise to record the meeting.